193 related articles for article (PubMed ID: 35145909)
1. CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets.
Kashima J; Hishima T; Okuma Y; Horio H; Ogawa M; Hayashi Y; Horiguchi SI; Motoi T; Ushiku T; Fukayama M
Front Oncol; 2021; 11():808396. PubMed ID: 35145909
[TBL] [Abstract][Full Text] [Related]
2. CD70 expression in thymic carcinoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Ooba T; Funata N; Koike M
Am J Surg Pathol; 2000 May; 24(5):742-6. PubMed ID: 10800994
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma.
Shan TT; Zhao X; Zhang Z; Wang JP; Zhang Y; Yang Y; Zhao S
Cancer Manag Res; 2020; 12():6909-6920. PubMed ID: 33204151
[TBL] [Abstract][Full Text] [Related]
4. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.
Ruf M; Mittmann C; Nowicka AM; Hartmann A; Hermanns T; Poyet C; van den Broek M; Sulser T; Moch H; Schraml P
Clin Cancer Res; 2015 Feb; 21(4):889-98. PubMed ID: 25691774
[TBL] [Abstract][Full Text] [Related]
5. CD70 and PD-L1 in anaplastic thyroid cancer - promising targets for immunotherapy.
Zwaenepoel K; Jacobs J; De Meulenaere A; Silence K; Smits E; Siozopoulou V; Hauben E; Rolfo C; Rottey S; Pauwels P
Histopathology; 2017 Sep; 71(3):357-365. PubMed ID: 28383817
[TBL] [Abstract][Full Text] [Related]
6. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
Benhamouda N; Sam I; Epaillard N; Gey A; Phan L; Pham HP; Gruel N; Saldmann A; Pineau J; Hasan M; Quiniou V; Nevoret C; Verkarre V; Libri V; Mella S; Granier C; Broudin C; Ravel P; De Guillebon E; Mauge L; Helley D; Jabla B; Chaput N; Albiges L; Katsahian S; Adam J; Mejean A; Adotevi O; Vano YA; Oudard S; Tartour E
Clin Cancer Res; 2022 Nov; 28(22):4983-4994. PubMed ID: 36067339
[TBL] [Abstract][Full Text] [Related]
7. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
8. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma.
Yokoyama S; Miyoshi H; Nakashima K; Shimono J; Hashiguchi T; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Clin Cancer Res; 2016 Sep; 22(18):4727-34. PubMed ID: 27166394
[TBL] [Abstract][Full Text] [Related]
10. CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients.
Inoue S; Ito H; Tsunoda T; Murakami H; Ebi M; Ogasawara N; Kasugai K; Kasai K; Ikeda H; Inaguma S
Virchows Arch; 2019 Oct; 475(4):425-434. PubMed ID: 30980190
[TBL] [Abstract][Full Text] [Related]
11. Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.
De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Rottey S; Ferdinande L
Pathology; 2017 Jun; 49(4):397-404. PubMed ID: 28427753
[TBL] [Abstract][Full Text] [Related]
12. Expression of the immune regulation antigen CD70 in osteosarcoma.
Pahl JH; Santos SJ; Kuijjer ML; Boerman GH; Sand LG; Szuhai K; Cleton-Jansen A; Egeler RM; Boveé JV; Schilham MW; Lankester AC
Cancer Cell Int; 2015; 15():31. PubMed ID: 25792975
[TBL] [Abstract][Full Text] [Related]
13. CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck.
De Meulenaere A; Vermassen T; Aspeslagh S; Zwaenepoel K; Deron P; Duprez F; Ferdinande L; Rottey S
Pathobiology; 2016; 83(6):327-33. PubMed ID: 27389010
[TBL] [Abstract][Full Text] [Related]
14. Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer.
Jacobs J; Zwaenepoel K; Rolfo C; Van den Bossche J; Deben C; Silence K; Hermans C; Smits E; Van Schil P; Lardon F; Deschoolmeester V; Pauwels P
Oncotarget; 2015 May; 6(15):13462-75. PubMed ID: 25951351
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer.
Baş Y; Koç N; Helvacı K; Koçak C; Akdeniz R; Şahin HHK
Transl Oncol; 2021 Feb; 14(2):100994. PubMed ID: 33333370
[TBL] [Abstract][Full Text] [Related]
16. The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.
Li S; Chen D; Guo H; Liu D; Yang C; Zhang R; Wang T; Zhang F; Bai X; Yang Y; Sun N; Zhang W; Zhang L; Zhao G; Peng L; Tu X; Tian W
Front Oncol; 2023; 13():1240061. PubMed ID: 37849799
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of CD70 and CD27.
Wajant H
Expert Opin Ther Targets; 2016 Aug; 20(8):959-73. PubMed ID: 26914723
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death-Ligand 1 Expression in Non-Small Cell Lung Carcinoma Biopsies and Its Association with Tumor Infi ltrat ing Lymphocytes and the Degree of Desmoplasia.
Tancoš V; Grendár M; Farkašová A; Huťka Z; Kviatkovská Z; Plank L
Klin Onkol; 2020; 33(1):55-65. PubMed ID: 32075390
[TBL] [Abstract][Full Text] [Related]
19. PAX5 and CD70 are expressed in thymic carcinoma but not in atypical thymoma (WHO type B3 thymoma): an immunohistochemical analysis of 60 cases.
Weissferdt A; Moran C
J Clin Pathol; 2023 Sep; ():. PubMed ID: 37696593
[TBL] [Abstract][Full Text] [Related]
20. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
